A dog’s chemotherapy protocol varies depending on the tumor type and stage, making a personalized approach essential for effective management. Here are the key factors to consider when selecting a protocol with your veterinarian.





| Item | Key Points |
|---|---|
| Concept | A treatment plan specifying drug combination, dosage, and schedule; differs by tumor type |
| Prerequisite | Determine the protocol in oncology care after biopsy and staging diagnosis |
| Administration principle | Adhere to the set dosage and schedule; do not change arbitrarily |
| Monitoring | Regular blood tests; observe and record appetite, energy, and vomiting |
| Caution | Do not replace or arbitrarily combine standard treatment with supplements claiming anticancer effects |
This is not a table recommending specific products or clinics, but criteria to reference when consulting a veterinarian. Treatment and testing decisions must always be made together with a veterinarian through an examination.
Caution: Drug Interactions and Contraindications
During chemotherapy, a dog’s response to and sensitivity of anticancer drugs can vary depending on the individual and breed. Certain breeds, such as Collies and Shelties, may be more sensitive to drugs like doxorubicin and vinca alkaloids due to an MDR1 (ABCB1) gene mutation. Therefore, always inform your veterinarian about all medications your dog is currently taking, as well as the dog’s breed and any underlying health conditions. Before combining other treatments or supplements, consult your veterinarian to ensure safety. Administer medications strictly according to the prescribed dosage and schedule, and never adjust them without veterinary guidance.


A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Adamo, M., Dickie, L. and Ruhl, J. (2018) SEER Program Coding and Staging Manual 2018. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, Maryland.
[2] London, C.A., Gardner, H.L., Mathie, R. et al. (2010) Metronomic chemotherapy: a systematic literature analysis. European Journal of Cancer 49(16), 3387–3395.
[3] Lien, K., Georgsdottir, S., Sivanathan, L. et al. (2013) Low-dose metronomic chemotherapy: a systematic literature analysis. European Journal of Cancer 49(16), 3387–3395.